Certolizumab pegol - PDFSEARCH.IO - Document Search Engine

Certolizumab pegol
Results: 53

#	Item
41	Cimzia(ß (certolizumab pegol) HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use CIMZIAQ! safely and effectively. See full prescribing information for CIMZIA. Add to Reading List Source URL: www.accessdata.fda.gov Language: English - Date: 2010-08-10 12:14:51 Immunology Certolizumab pegol Rheumatoid arthritis Anakinra Etanercept Rituximab Tumor necrosis factor-alpha Latent tuberculosis Tuberculosis treatment Medicine Immunosuppressants Pharmacology
42	HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use CIMZIA® safely and effectively. See full prescribing information for CIMZIA. Add to Reading List Source URL: www.accessdata.fda.gov Language: English - Date: 2012-08-31 14:12:04 Biology Certolizumab pegol Rheumatoid arthritis Anakinra Etanercept Rituximab Tumor necrosis factor-alpha Latent tuberculosis Placebo Medicine Immunosuppressants Pharmacology
43	2 Downloaded from www.bbc.co.uk/radio4 THE ATTACHED TRANSCRIPT WAS TYPED FROM A RECORDING AND NOT COPIED FROM AN ORIGINAL SCRIPT. BECAUSE OF THE RISK OF MISHEARING AND THE DIFFICULTY IN SOME CASES OF IDENTIFYIN Add to Reading List Source URL: downloads.bbc.co.uk Language: English - Date: 2010-07-30 10:45:38 Immunosuppressants Arthritis Connective tissue diseases NHS England Rheumatoid arthritis National Institute for Health and Clinical Excellence Certolizumab pegol Alternative medicine Pharmaceutical industry Health Medicine Rheumatology
44	PDF Document Add to Reading List Source URL: www.phusewiki.org Language: English - Date: 2013-04-23 07:04:44 Clinical Data Management Clinical trials Immunosuppressants Food and Drug Administration Biotechnology Certolizumab pegol SDTM Clinical Data Interchange Standards Consortium Arthritis Medicine Clinical research Health
45	Wilcox Pharmacy/Option Care Respiratory Syncytial Virus (RSV) Prophylaxis Add to Reading List Source URL: dvha.vermont.gov Language: English - Date: 2014-06-03 15:06:43 Arthritis Immunosuppressants Biotechnology Certolizumab pegol Medical prescription Syringe Rheumatoid arthritis Psoriatic arthritis Medicine Health Pharmacology
46	For more information about the Organization of Teratology Information Specialists Add to Reading List Source URL: www.mothertobaby.org Language: English - Date: 2013-11-13 16:23:35 Immunosuppressants Biotechnology Gastroenterology Monoclonal antibodies Autoimmune diseases Certolizumab pegol TNF inhibitor Infliximab Tumor necrosis factor-alpha Medicine Biology Health
47	HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use CIMZIA® safely and effectively. See full prescribing information for CIMZIA. Add to Reading List Source URL: www.accessdata.fda.gov Language: English - Date: 2012-11-16 15:17:23 Biology Certolizumab pegol Anakinra Rheumatoid arthritis Etanercept Rituximab Latent tuberculosis Tumor necrosis factor-alpha Tuberculosis treatment Medicine Immunosuppressants Pharmacology
48	HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use CIMZIA® safely and effectively. See full prescribing information for CIMZIA. Add to Reading List Source URL: www.accessdata.fda.gov Language: English - Date: 2012-08-03 11:03:50 Biology Certolizumab pegol Rheumatoid arthritis Anakinra Rituximab Etanercept Tumor necrosis factor-alpha Tuberculosis treatment Latent tuberculosis Medicine Immunosuppressants Pharmacology
49	For more information about the Organization of Teratology Information Specialists or to find a service in your area, call[removed]or visit us online at: www.OTISpregnancy.org. Certolizumab Pegol and Pregnancy In e Add to Reading List Source URL: www.mothertobaby.org Language: English - Date: 2013-06-17 14:04:25 Immunosuppressants Biotechnology Gastroenterology Monoclonal antibodies Autoimmune diseases Certolizumab pegol TNF inhibitor Infliximab Tumor necrosis factor-alpha Medicine Biology Health
50	23 January 2014 EMA/CHMP[removed]Committee for Medicinal Products for Human Use (CHMP) Summary of opinion 1 (initial authorisation) Add to Reading List Source URL: www.ema.europa.eu Language: English - Date: 2014-01-24 07:02:26 Drug safety Clinical research European Medicines Agency Pharmaceutical industry Committee for Medicinal Products for Human Use Summary of Product Characteristics Pharmacovigilance Antipsychotic Certolizumab pegol Pharmaceutical sciences Pharmacology Health

UPDATE